Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)
a study on Achondroplasia
- for people ages 30 months to 10 years (full criteria)
- at Oakland, California and other locations
- study startedestimated completion
- Principal Investigator
- by Paul Harmatz, M.D.
Achondroplasia, Skeletal dysplasia, Endochondral ossification, ACH, Shortened proximal limbs, Fibroblast growth factor receptor 3, FGFR3, Endochondral bone formation, Short-limb disproportionate dwarfism, Bone disease, Dwarfism, Bone diseases, Musculoskeletal diseases, Osteochondrodysplasia, Genetic diseases, Inborn
Lead Scientist at UCSF
- Paul Harmatz, M.D.
Professor, Pediatrics, School of Medicine. Authored (or co-authored) 211 research publications
- accepting new patients
- Start Date
- Completion Date
- QED Therapeutics, Inc.
- Related Info
- Study Type
- Expecting 200 study participants
- Last Updated